What Is Rose-Derived PDRN?

Rose-Derived PDRN represents one of the most significant raw material shifts in cosmetic formulation science this decade. At Xi'an Le-Nutra Ingredients Inc., we have spent over 14 years in the plant extraction industry, and we have seen ingredient trends come and go. This one is different. It is not a marketing story. It is a formulation decision that affects sourcing, stability testing, regulatory claims, and consumer positioning.

The global PDRN skincare market is projected to grow from $321 million in 2025 to $811 million by 2035, at a CAGR of 9.7%. For B2B buyers and cosmetic manufacturers, the more important question is not whether to use PDRN, but which source to use. Rose-derived PDRN offers a plant-based alternative with a molecular profile and phytochemical composition that deliver specific advantages for sensitive-skin, vegan, and clean-beauty formulations. This guide covers the technical fundamentals that formulators and procurement teams need before evaluating this ingredient.

Polydeoxyribonucleotide (PDRN) is a mixture of DNA fragments that exerts biological effects through adenosine A2A receptor activation and the salvage pathway. In simple terms, PDRN supplies the building blocks that skin cells use to repair themselves and stimulates the biological signals that trigger collagen synthesis and anti-inflammatory responses.

Rose-Derived PDRN was first extracted from salmon sperm cells and has been used in injectable dermatology for decades. It shares approximately 98% homology with human DNA, which is one reason it integrates so well into human skin biology. The cosmetic industry later adopted PDRN as a topical active, and the raw material has since expanded from marine sources to plant-based alternatives.

The botanical extraction route is the primary differentiator. Rose-Derived PDRN is extracted from Damask rose (Rosa Damascena) petals and other rose plant materials through a controlled, low-temperature process that preserves the integrity of the DNA fragments while simultaneously capturing the plant's native phytochemicals. This co-extraction is not a byproduct. It is a deliberate design feature that shapes the ingredient's performance profile.

A representative commercial Rose-Derived PDRN product contains 10% PDRN with 99% purity. The remaining 90% consists of rose phytochemicals, including approximately 4% polyphenols, 0.6% flavonoids, and glycoproteins. These co-extracted compounds contribute antioxidant activity, barrier support, and anti-inflammatory benefits that are not present in purified salmon PDRN.

From a formulation standpoint, this phytochemical co-fraction means the ingredient can serve dual functions in a formula: as a PDRN active and as a supporting antioxidant/soothing component. For manufacturers developing streamlined ingredient lists, this reduces the need for additional botanical extracts.

Damask rose polyphenols and estrogen-like compounds have been measured at levels up to 8× higher than pomegranate, contributing to brightening and anti-aging benefits alongside the PDRN itself. The petals are also rich in vitamin C, phenolic compounds, and flavonoids, which help neutralize free radicals and protect against environmental stress.

The table below compares the two PDRN sources across key formulation parameters:

Market Growth

The Rose-Derived PDRN skincare market is expanding rapidly, but the source mix is shifting. A 2026 innovation report found that 33% of all PDRN innovations filed in the prior 12 months claim non-marine sources. Three years ago, that number was negligible. Retail certifications including Sephora Clean, Leaping Bunny, and PETA are blocking salmon-derived PDRN, and brands without a plant-derived or fermentation-route source by 2027 will be locked out of the fastest-growing retail certification channel.

For B2B manufacturers and brand owners, this is a procurement planning issue. Identifying a compliant PDRN source now prevents supply chain disruption later.

Clinical Evidence for Plant-Derived PDRN

The clinical evidence base for plant-derived PDRN is growing. A December 2025 clinical trial on peony PDRN became the first published human topical efficacy data for any plant-derived PDRN source. In that study, low-molecular-weight peony PDRN enhanced skin cell proliferation and migration, upregulated extracellular matrix genes including COL1A1, COL5A1, ELN, and FBN1, and promoted keratinocyte differentiation and epidermal barrier formation. Topical application for two weeks significantly reduced transepidermal water loss, and periorbital skin elasticity improved after four weeks of treatment.

Another study comparing a medium-length PDRN preparation (PDRN-850K) with retinol in a randomized, double-blind, split-face trial found that PDRN-850K achieved approximately two-fold greater improvements in periocular wrinkles, dermal thickness, density, and eye bag parameters compared with retinol over 28 days. The mechanism was traced to PI3K–Akt, TGF-β/Smad, and autophagy-related signaling pathway activation in basal fibroblasts.

For formulators, the practical takeaway is that PDRN molecular weight matters. Low-molecular-weight fractions showed stronger effects on cell proliferation and barrier-related gene expression, while medium-length fractions delivered the most robust clinical wrinkle improvement. Understanding this distinction helps formulators select the right PDRN specification for their intended product claims.

Rose-Derived PDRN molecular weight distribution is not a minor technical detail. It directly influences cellular uptake, bioactivity, and formulation behavior. Commercial PDRN products typically specify molecular weights between 50 and 1,500 kDa, as measured by size-exclusion chromatography.

The following table summarizes the relationship between molecular weight fraction and biological activity, based on published research:

For formulators, the practical takeaway is that PDRN molecular weight matters. Low-molecular-weight fractions showed stronger effects on cell proliferation and barrier-related gene expression, while medium-length fractions delivered the most robust clinical wrinkle improvement. Understanding this distinction helps formulators select the right PDRN specification for their intended product claims.

When sourcing PDRN, ask your supplier for the molecular weight distribution data for the specific batch, not just a general specification range. Batch-to-batch consistency in molecular weight profile is a key quality indicator.

Solubility and Incorporation

Rose-Derived PDRN is typically supplied as a water-soluble powder or in a pre-dissolved liquid format. For powder formats, dissolution in the water phase at temperatures below 40°C is recommended to preserve DNA fragment integrity. Adding the ingredient during the cooling phase of emulsion preparation reduces thermal exposure.

pH and Stability

PDRN is sensitive to hydrolytic instability and pH fluctuation. Published formulation data suggest a pH range of 5.0–7.0 for optimal stability in water-based systems. The absorbance ratio at 260/280 nm, which indicates DNA purity, should fall between 1.5 and 2.0 for cosmetic-grade material.

Preservative Compatibility

PDRN interacts with certain preservative systems. Phenoxyethanol-based preservation is generally compatible, but high concentrations of cationic preservatives may affect PDRN stability. Formulators should conduct compatibility testing with their chosen preservation system during development.

Claim Language Considerations

In the EU, cosmetic products must comply with strict ingredient safety assessments and claim substantiation standards. In the US, the FDA's intended-use doctrine means that claims implying tissue repair or wound healing may trigger drug classification. Cosmetic-safe claim language should focus on appearance-related benefits: supporting the look of smoother, healthier skin, improving visible firmness, and reducing the appearance of fine lines.

For procurement teams and product development managers, the supplier evaluation process should cover the following areas:

• Documentation

Request a batch-specific Certificate of Analysis covering PDRN content, purity, molecular weight distribution, microbial limits, and heavy metals. Third-party testing adds credibility. The industry is moving toward standardized PDRN testing methods including UV spectrophotometry, gel electrophoresis, and PCR-based source identification.

• Raw material sourcing

Rose PDRN quality depends on the botanical source. Suppliers working with certified organic farms and long-term contracts offer more consistent phytochemical profiles than those relying on spot-market purchasing.

• Customization capability

OEM/ODM support varies significantly. Some suppliers offer standard specifications; others can adjust PDRN concentration, molecular weight fraction, dosage form (powder, liquid, or encapsulated), and packaging to match specific formulation requirements.

• Scalability

For brands planning commercial launch, confirm the supplier's production capacity and lead times. A manufacturer with a 60,000㎡ production base and 3,000 tons annual capacity can support both pilot batches and large-volume repeat orders.

• Regulatory support

Ask what documentation the supplier can provide for your target markets: safety data, purity standards, traceability records, and compliance certifications.

The table below outlines how different molecular weight specifications of Rose powder PDRN map to common product categories:

Rose-Derived powder PDRN integrates well into water-based serums, emulsions, and hydrogel formats. Its water solubility and compatibility with common cosmetic preservatives make it straightforward to incorporate into existing formulation platforms. The key constraint is thermal exposure during manufacturing, which is manageable with standard cooling-phase addition protocols.

Rose-Derived PDRN is not simply a vegan substitute for salmon PDRN. It is a differentiated raw material with a distinct molecular profile, co-extracted phytochemicals, and a supply chain story that aligns with where the cosmetic market is heading. The clinical evidence base is expanding. The regulatory environment is tightening around animal-derived biologics. Retail certification channels are increasingly blocking marine sources.

For formulators, the decision comes down to three questions: What molecular weight fraction matches your target claim? What documentation does your target market require? Can your supplier deliver consistent quality at the volume you need? Answering these questions upfront determines whether Rose-Derived PDRN becomes a competitive advantage or a formulation headache.

Xi'an Le-Nutra Ingredients Inc. has been in the plant extract industry for over 14 years. Our 60,000㎡ production base and 3,000 tons annual production capacity support large-volume orders and flexible OEM/ODM projects. We operate 6 multifunctional production lines with various extraction tanks, processing a wide range of plant materials at custom purities and specifications.

Our R&D and QC teams conduct third-party testing for every batch, with compliance certifications covering GMP, ISO, and FDA standards. We maintain a stable raw material supply chain from certified organic farms, with 30+ days of safety stock and long-term logistics partnerships, ensuring 98% on-time delivery for global orders.

We work with cosmetic brands, contract manufacturers, and distributors across North America, Europe, and Southeast Asia. Whether you are evaluating Rose PDRN for a new product line or looking for a reliable long-term supplier, our team can provide samples, technical documentation, and formulation support.

Xi'an Le-Nutra Ingredients Inc.

Address: Room 21111, 21112, Building D, Haibo Square, Fengcheng 9 Road, ETDZ, Xi'an, Shaanxi, China
Tel: 86-29-86518603
Email: info@lenutra.com | aimee@lenutra.com
WhatsApp: +86 15209233790
Website: https://www.lenutra.com/